Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin + Fotemustine in Metastatic Melanoma
NCT01069627Phase 2Completed
- Sponsor
- Roche
- Start
- Dec 2006
- Primary completion
- Jul 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in melanoma, sponsored by Roche. Started Dec 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01069627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01069627.